Stericycle Continues to Dissappoint Investors
Stericycle (SRCL) continues to have issues with its new business lines, and now expects flatish profit growth for 2017 and 2018.
Stericycle (SRCL) continues to have issues with its new business lines, and now expects flatish profit growth for 2017 and 2018.
Stericycle’s (SRCL) dealing with some issues right now. But with SRCL half the price it was a year ago, is this the time to buy?
Stericycle (SRCL) is having growing pains as it expands from medical waste into industrial and paper waste. With the stock down, is this time to buy?
Stericycle (SRCL) fell late last year when profit growth fell flat. Now growth looks to accelerate during the 2nd half of 2016.
Stericycle (SRCL) dropped from $150 to $120 after it missed estimates. Let’s see if this is a buying opportunity.
Stericycle (SRCL) delivers double-digit profit growth year-after-year. But SRCL’s price is high.